FDA set to authorize Pfizer-BioNTech COVID-19 vaccine for adolescents early next week: NYT
By Trisha Roy, ReutersPosted on
FILE PHOTO: Vials of Pfizer’s coronavirus disease (COVID-19) vaccine are seen at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., February 23, 2021.
REUTERS/Brendan McDermid
Sign up for our amNewYork email newsletter to get news, updates, and local insights delivered straight to your inbox!
The U.S. Food and Drug Administration is preparing to authorize Pfizer Inc and BioNTech SE’s COVID-19 vaccine for adolescents aged between 12 and 15 years by early next week, the New York Times reported on Monday, citing federal officials familiar with the agency’s plans.
This is a developing story. Check back for more details.
